SCHEMBL6604221

SCHEMBL6604221

Cc1ccc(S(=O)(O)=S)cc1Cc1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.44
LMNA P02545 4/20 0.39
KMT2A Q03164 2/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
ALDH1A1 P00352 4/20 0.39
POLB P06746 3/20 0.39
THRB P10828 1/20 0.39
KCNJ6 P48051 1/20 0.39
KCNJ5 P48544 1/20 0.39
KCNJ3 P48549 1/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPK1 P28482 1/20 0.38
HPGD P15428 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ESR1 P03372 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6962964 0.90 PTGS2 (0.43) PTGS2LMNAKMT2AALDH1A1POLB
SCHEMBL6604217 0.82 PTGS2 (0.46) PTGS2LMNAKMT2APDE3BPDE3A
SCHEMBL6605223 0.82 TAS2R14 (0.41) PTGS2LMNAKMT2AALDH1A1POLB
SCHEMBL6602940 0.82 CYP3A4 (0.46) ALDH1A1
SCHEMBL6604584 0.82 TAAR1 (0.40) KMT2AALDH1A1POLBSMN1; SMN2GAA
SCHEMBL6604218 0.76 LMNA (0.40) PTGS2LMNAKMT2APDE3BPDE3A
SCHEMBL6604230 0.75 ALDH1A1 (0.41) LMNAKMT2AALDH1A1POLBSMN1; SMN2
SCHEMBL9718454 0.75 LMNA (0.44) LMNAPDE3BPDE3ATP53SMN1; SMN2
SCHEMBL10886550 0.74 FFAR4 (0.38) LMNAALDH1A1MAPTESR1
SCHEMBL6603886 0.73 TDP1 (0.41) LMNAKMT2AALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed